This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stock Strategies From Wall Street: Feb. 9 (Update 1)

Updated with stock ratings.

NEW YORK ( TheStreet) -- The world of vitamins and car stocks is calling, but housing is another story. Wall Street analysts explain which nutrition retailers make for good stocks and why investors should be careful picking homebuilding stocks this month:

1) Vitamins Are Good For You

Demand for vitamins may boost the stocks of nutrition retailers.

JP Morgan analysts say the vitamin industry is expected to grow 4% to 5% domestically. People are paying more attention to healthy living, consumers are more open to nutritional products and an aging population is increasingly focused on health issues. All of these trends, the firm says, will help drive growth.

"Americans love 'magic in a bottle' and [the industry] can be viewed as an inexpensive offense/defense to health challenges," writes the firm.

The firm's top pick stock remains GNC Acquisition Holdings (GNC - Get Report). "GNC is in the heart of the momentum lift... the combination of strong product sales through company-owned stores and higher margin domestic and international franchises, third-party contract manufacturing, e-commerce and corporate partnerships highlights GNC's potential for consistent earnings upside," it explains.

The second stock JP Morgan likes is Vitamin Shoppe (VSI - Get Report), although this company, it says, may be better for the long term. "We like VSI for many of the same reasons as GNC," it writes.

However, the firm notes that Vitamin Shoppe is a "classic retail growth story" with less exposure to growth in sport nutrition. "GNC has more levers to pull for EPS upside given its multiple divisions and improved brand management while VSI doesn't annualize stepped up expenses until the third quarter of 2012." In other words, GNC looks like a better short-term play but won't be able to beat out VSI in the long run.

JP Morgan estimates that total revenue in the vitamins, mineral and supplements industry will have risen 6% in 2011, after 5% in 2010. "The largest drivers from 2005 have been vitamins, sports nutrition and specialty supplements, with average annual growth in the high single digits. For 2012, we expect continued solid mid-single digit growth," it writes.

GNC is rated a strong buy by five of eight analysts covering the stock, according to TheStreet Ratings. Vitamin Shoppe is rated a strong buy by eight of 14 analysts covering the stock and a hold stock by four analysts.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ZX $0.93 -2.11%
ABC $78.00 -7.46%
BECN $42.40 -0.33%
BCOM $27.47 -3.38%
CAAS $4.14 -2.13%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs